PRLR regulates hepatic insulin sensitivity in mice via STAT5

Area of Science:

• Metabolic disease research
• Endocrinology
• Molecular biology

Background:

• Insulin resistance is a key factor in metabolic diseases, but its mechanisms are not fully understood.
• The prolactin receptor (PRLR) has known functions, but its direct impact on insulin sensitivity was unexplored.

Purpose of the Study:

• To investigate the role of the prolactin receptor (PRLR) in regulating insulin sensitivity.
• To elucidate the molecular mechanisms underlying PRLR's effect on insulin sensitivity.

Main Methods:

• In vivo studies using adenovirus to overexpress or knock down PRLR in mice.
• In vitro experiments to assess PRLR's effect on insulin sensitivity.
• Analysis of the signal transducer and activator of transcription-5 (STAT5) pathway.
• Examination of PRLR expression in insulin-resistant (db/db mice) and insulin-sensitive (leucine deprivation) models.
• Investigation of the GCN2/mTOR/S6K1 pathway in regulating PRLR expression.

Main Results:

• Overexpression of PRLR improved insulin sensitivity, while knockdown impaired it in mouse models and in vitro.
• The STAT5 pathway is essential for PRLR-mediated regulation of insulin sensitivity.
• PRLR expression inversely correlated with insulin resistance, decreasing in db/db mice and increasing with leucine deprivation.
• Altering PRLR levels reversed insulin sensitivity in both resistant and sensitive conditions.
• Leucine deprivation increased hepatic PRLR expression via the GCN2/mTOR/S6K1 pathway.

Conclusions:

• Hepatic PRLR has a novel function in regulating insulin sensitivity.
• PRLR expression is subject to nutritional regulation, impacting metabolic homeostasis.
• These findings offer new therapeutic targets for metabolic diseases related to insulin resistance.